RHEUMATOLOGY & CLINICAL IMMUNOLOGY

We are at the forefront of clinical innovation in rheumatology and clinical immunology, focusing on improving outcomes for patients suffering from chronic, debilitating autoimmune and inflammatory diseases. These conditions not only impact physical health but also significantly affect quality of life, productivity, and long-term well-being.

Our research supports the development of advanced therapies—biologics, targeted synthetic drugs, and immunomodulators—that aim to reduce inflammation, prevent joint and organ damage, and enhance functional outcomes.

rheumatology

Core Research Areas:

  • Rheumatoid Arthritis (RA)
  • Systemic Lupus Erythematosus (SLE)
  • Psoriatic Arthritis (PsA)
  • Ankylosing Spondylitis and Axial Spondyloarthritis
  • Systemic Sclerosis (Scleroderma)
  • Vasculitis Syndromes
  • Sjogren’s Syndrome
  • Juvenile Idiopathic Arthritis (JIA)
  • Gout and Crystal Arthropathies
  • Immunodeficiency and Autoinflammatory Disorders

Our Research Capabilities:

  • Collaboration with expert rheumatologists and immunologists across hospital and specialty clinic networks
  • Early-phase and late-phase trials including disease-modifying antirheumatic drugs (DMARDs), biologics, JAK inhibitors, and monoclonal antibodies
  • Comprehensive biomarker analysis to track disease progression and treatment response
  • Advanced imaging systems (MRI, ultrasound) for objective joint and soft tissue assessment
  • Central Laboratory Services for autoantibody profiling, cytokine panels, and genetic screening
  • Electronic Data Capture (EDC) designed for long-term, real-world data collection
  • IVRS/IWRS Systems for adaptive trial designs and randomized controlled studies
  • CTMS for regulatory-compliant trial monitoring and reporting

Our Approach:

We place strong emphasis on patient-centered study design, ensuring that trials are accessible, ethical, and scientifically sound. By integrating clinical expertise with real-world data, we contribute to the global effort to personalize care for patients with rheumatic and immunological diseases.

We are proud to work with sponsors, investigators, and healthcare providers to bring new hope to patients living with lifelong autoimmune conditions—through research that delivers.